-+ 0.00%
-+ 0.00%
-+ 0.00%

IMMUTEP - ANNOUNCES RESULTS FROM 5 CLINICAL TRIALS OF EFTILAGIMOD ALFA IN LATE-STAGE CANCER

Reuters·05/28/2026 12:10:41

Please log in to view news